Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lixte Biotechnology Holdings Inc.

1.13
-0.0946-7.72%
Post-market: 1.180.0486+4.30%16:00 EDT
Volume:458.00
Turnover:541.82
Market Cap:3.04M
PE:-0.71
High:1.22
Open:1.22
Low:1.13
Close:1.23
Loading ...
Dec 17, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 02, 2020

Major Issues Report

8-K - Current report
Nov 27, 2020

Major Issues Report

8-K - Current report
Nov 19, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 19, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 16, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 16, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 16, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 13, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 03, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 18, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 17, 2020

Major Issues Report

8-K - Current report
Jul 17, 2020

Major Issues Report

8-K - Current report
May 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 25, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 08, 2019

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2019

Major Issues Report

8-K - Current report